BioBlast Pharma's Series A Round

BioBlast Pharma raised a round of funding on February 13, 2014. Investors include Pontifax.

BioBlast Pharma is a privately held, clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Founded in 201…

Articles about BioBlast Pharma's Series A Round: